Exclusive

Publication

Byline

SNUBH achieves global healthcare accreditation

Singapore, Nov. 5 -- Seoul National University Bundang Hospital (SNUBH) in Seoul, South Korea has been awarded a three-year term of accreditation by the Global Healthcare Accreditation (GHA) Program f... Read More


Boehringer Ingelheim and Lilly modernise alliance

Singapore, Nov. 5 -- In a move to better serve people living with and without diabetes, Boehringer Ingelheim and Eli Lilly and Company will modernise their current alliance as of 1 January 2020 and fo... Read More


Takeda divests select OTC to STADA for $660M

Singapore, Nov. 5 -- Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG, an international pharm... Read More


Cerecin strengthens its leadership position in CNS drug development

Singapore, Nov. 5 -- Cerecin, a global healthcare company focused on developing brain health solutions and therapeutics for patients around the world, on 4 Nov 2019, announced the appointment of Bruce... Read More


Janssen Korea announces winners for Innovation QuickFire Challenge in Smart Healthcare

Singapore, Nov. 5 -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, in collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute (KHIDI), have anno... Read More


Shimmer Receives CE Certification for ECGmd Holter Monitor Electrocardiograph

Singapore, Nov. 5 -- Shimmer Research, a global leader in wearable technology for research applications, on 4 Nov 2019, announced that ECGmd - its five-wire, four-lead holter monitor electrocardiograp... Read More


FDA approves Sanofi's Influenza Vaccine for older people

Singapore, Nov. 5 -- The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone(R) High-Dose Quadrivalent (Influenza Vaccine) for use in adults 6... Read More


Samsung Biologics collaborates with Ichnos Sciences in derma space

Singapore, Nov. 5 -- Samsung Biologics has announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in develop... Read More


Aeromics, Simcere team up for anti-edema therapy in Greater China

Singapore, Nov. 5 -- Simcere Pharmaceutical Group and Aeromics, Inc. have announced collaboration and exclusive license agreement for AER-271, a clinical-stage anti-edema therapy, being developed for ... Read More


SciRhom Initiates First-In-Class Program to treat major Autoimmune Diseases

Singapore, Nov. 5 -- SciRhom GmbH, a therapeutic antibody company, announced on 5 Nov 2019 its development of first-in-class antibodies against iRhom2, a key modulator of several major pro-inflammator... Read More